check_circleStudy Completed

Bacterial Infections

Bayer Identifier:

Trial_100169

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Comparison of ciprofloxacin versus control regimens in the treatment of pediatric subjects with complicated urinary tract infections (UTI) or pyelonephritis

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
689
Trial Dates
September 1999 - June 2003
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Cipro (Ciprofloxacin, BAYQ3939)
Accepts Healthy Volunteer
N/A

Trial design

A prospective, randomized study to compare ciprofloxacin (either as oral suspension or as IV or sequential IV→oral suspension therapy) versus control regimens (either trimethoprim/sulfamethoxazole (TMP/SMX) oral suspension, cefixime oral suspension, IV ceftazidime, sequential IV ceftazidime→trimethoprim/sulfamethoxazole oral suspension therapy or sequential IV ceftazidime →PO cefixime) in the treatment of pediatric subjects with complicated urinary tract infections (UTI) or pyelonephritis
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.